Last update 20 Mar 2025

Shendan Huoxue Capsule

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersRespiratory Diseases+ [1]
Active Indication
Female Genital NeoplasmsLung CancerRectal Cancer
Inactive Indication-
Originator Organization
Beijing Tong RenTang Co., Ltd.Beijing Tong RenTang Co., Ltd.
Active Organization
Beijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical FactorBeijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical Factor
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (27 May 2019),
Female Genital NeoplasmsLung CancerRectal Cancer
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Shendan Huoxue Capsule
CTR20132338
/ RecruitingPhase 4
参丹活血胶囊治疗稳定性劳力性冠心病心绞痛（气阴两虚兼血瘀证）安全性和有效性的开放、多中心临床试验
[Translation] An open, multicenter clinical trial on the safety and efficacy of Shendan Huoxue Capsule in the treatment of angina pectoris in stable exertional coronary heart disease (Qi and Yin deficiency with blood stasis syndrome)
100 Clinical Results associated with Shendan Huoxue Capsule
Login to view more data
100 Translational Medicine associated with Shendan Huoxue Capsule
Login to view more data
100 Patents (Medical) associated with Shendan Huoxue Capsule
Login to view more data
100 Deals associated with Shendan Huoxue Capsule
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Female Genital Neoplasms
China
Beijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical FactorBeijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical Factor
27 May 2019
Lung Cancer
China
Beijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical FactorBeijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical Factor
27 May 2019
Rectal Cancer
China
Beijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical FactorBeijing Tongrentang Co. Ltd. Tongrentang Pharmaceutical Factor
27 May 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free